Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-02

Clinical Trial Update: Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Pilot Trial) [NA]

View source ↗

Summary

This clinical trial update indicates that the pilot study evaluating Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for balance deficits after mild trauma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cranial-nerve Non-invasive Neuromodulation (CN-NINM)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Mild Traumatic Brain Injury | NA | Status: WITHDRAWN